PTPRC and neoplasm: Flow cytometry of single cell tumor suspensions to evaluate for TIL revealed a trend towards greater infiltration of CD45+, CD45+ CD3+ and CD4+ cells with BATs compared to all other treatment groups that neared significance (p = 0.057) (Fig. 4B).